Bavarian Nordic A/S
BAVA
Clasificación en acciones
#5065
Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in... Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in the research, production, and global distribution of vital, life-saving vaccines. The company's commercialized offerings include non-replicating vaccines for smallpox and monkeypox, marketed as IMVAMUNE, IMVANEX, and JYNNEOS. Additionally, their portfolio features Rabipur/RabAvert for rabies prevention, Encepur for tick-borne encephalitis, and MVABEA, an Ebola vaccine. Bavarian Nordic also maintains a robust pipeline of investigational treatments. This includes MVA-BN (freeze-dried), which has successfully completed Phase III clinical trials for smallpox; MVA-BN RSV, currently in Phase III development for respiratory syncytial virus; ABNCoV2, which completed Phase II trials targeting SARS-CoV-2; and TAEK-VAC, presently in Phase I/II trials for advanced HER2 and brachyury-expressing cancers. The firm engages in key partnerships, notably a license and collaboration agreement with AdaptVac, and licensing agreements with both the National Cancer Institute and the Public Health Service. Bavarian Nordic operates across a wide international footprint, with a presence in countries such as the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and numerous other global markets.
Precio por acción
$37.53
Capitalización bursátil
$2.85B
Cambio (1 día)
-0.59%
Cambio (1 año)
0.84%
País
DK
Comercio Bavarian Nordic A/S (BAVA)
Categoría
Healthcare
Capitalización de mercado de Bavarian Nordic A/S(BAVA)
Capitalización bursátil: $2.85B
A fecha de October 2026, Bavarian Nordic A/S tiene una capitalización de mercado de $2.85B. Esto convierte a Bavarian Nordic A/S en la 5065th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Bavarian Nordic A/S desde 2003 hasta 2026
BAVA en comparación con los más populares 5 títulos stocks
